Soni Medicare's Stock Reaches 52-Week High, Outperforms Sensex in 1-Year Performance

Nov 04 2024 10:05 AM IST
share
Share Via
Soni Medicare, a microcap company in the healthcare industry, has reached a 52-week high of Rs. 42.1 on November 4th, 2024. Despite a 'Sell' call from MarketsMojo, the stock has shown a positive trend in the past four days and is currently trading above its moving averages. With a 1-year performance of 52.13%, the company has outperformed the Sensex, showcasing its growth potential and potential as a promising investment opportunity in the healthcare sector.


Soni Medicare, a microcap company in the hospital and healthcare services industry, has recently reached a 52-week high in its stock price. On November 4th, 2024, the company's stock hit a high of Rs. 42.1, which is a significant milestone for the company.

According to MarketsMOJO, a leading stock analysis and recommendation platform, the current call for Soni Medicare's stock is 'Sell'. However, the company's recent performance has been noteworthy. Despite underperforming the sector by -4.28% today, the stock has shown a positive trend in the past four days. It opened with a gain of 2.01% today and touched an intraday high of Rs. 42.1.

On the other hand, the stock also saw a dip in its price, touching an intraday low of Rs. 39.22, which is a decrease of -4.97%. This could be attributed to profit booking by investors after the recent surge in the stock price.

Soni Medicare's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the company's performance.

In terms of overall performance, Soni Medicare has outperformed the Sensex, with a 1-year performance of 52.13% compared to Sensex's 22.44%. This showcases the company's strong growth potential and its ability to generate returns for its investors.

As a microcap company, Soni Medicare may not be on the radar of many investors. However, its recent stock price surge and positive performance indicate that it could be a promising investment opportunity in the healthcare industry. Investors should keep an eye on the company's future developments and performance to make informed investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News